Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy

Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers

(2012) Matteo Ferro et al.   CLINICA CHIMICA ACTA

Tumor markers in prostate cancer I: Blood-based markers

(2011) Shahrokh F. Shariat et al.   ACTA ONCOLOGICA

Tumour markers in prostate cancer III: Biomarkers in urine

(2011) Monique J. Roobol et al.   ACTA ONCOLOGICA

Contemporary role of prostate cancer gene 3 in the management of prostate cancer

(2011) Monique J Roobol   CURRENT OPINION IN UROLOGY

Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer

(2011) Marco Auprich et al.   EUROPEAN UROLOGY

Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer

(2011) Giorgio Guazzoni et al.   EUROPEAN UROLOGY

Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions

(2011) Alexandre de la Taille et al.   JOURNAL OF UROLOGY

Extended Sampling at First Biopsy Improves Cancer Detection Rate: Results of a Prospective, Randomized Trial Comparing 12 Versus 18-Core Prostate Biopsy

(2011) Francisco Rodríguez-Covarrubias et al.   JOURNAL OF UROLOGY

Diagnostic performance of the PCA3 urine test

(2011) George Leighton Lee et al.   Nature Reviews Urology

A Three-Gene panel on urine increases PSA specificity in the detection of prostate cancer

(2011) Marina Rigau et al.   PROSTATE

ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program

(2011) Sumit Isharwal et al.   UROLOGY

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

(2010) Guillaume Ploussard et al.   BJU INTERNATIONAL

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

(2010) Amine Benchikh et al.   BMC CANCER

PCA3: From basic molecular science to the clinical lab

(2010) John R. Day et al.   CANCER LETTERS

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum

(2010) Axel Semjonow et al.   CLINICAL BIOCHEMISTRY

Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

(2010) Flip H. Jansen et al.   EUROPEAN UROLOGY

A Panel of TMPRSS2:ERG Fusion Transcript Markers for Urine-Based Prostate Cancer Detection with High Specificity and Sensitivity

(2010) Phuong-Nam Nguyen et al.   EUROPEAN UROLOGY

Prostate Cancer Detection in the “Grey Area” of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun’s Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3

(2010) Sisto Perdonà et al.   EUROPEAN UROLOGY

Urine biomarkers in prostate cancer

(2010) Guillaume Ploussard et al.   Nature Reviews Urology

A note on adaptive Bonferroni and Holm procedures under dependence

(2009) W. Guo   BIOMETRIKA

Pro-Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer

(2009) D. V. Makarov et al.   CLINICAL CANCER RESEARCH

Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program

(2009) Jeffrey J. Tosoian et al.   JOURNAL OF UROLOGY

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

(2008) Alexander Haese et al.   EUROPEAN UROLOGY

Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus StatementStandard Operating Procedure Integration Working Group

(2008) Melissa K. Tuck et al.   JOURNAL OF PROTEOME RESEARCH

A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases

(2008) Carsten Stephan et al.   PROSTATE